ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home WCLC News

KEYNOTE-604 Follow-Up Results Continue to Show Clinically Meaningful Improvement

Cody Holt
on: October 11, 2022In: Meeting News, WCLC News
KEYNOTE-604 Follow-Up Results Continue to Show Clinically Meaningful Improvement

Long-term data presented by Dr. Charles Rudin during WCLC 2022 showed significant OS benefit for patients with extensive stage SCLC on pembrolizumab combination versus placebo. Read more


Study Shows Shorter-Term Assessments Underestimate Pollution Exposure

Cody Holt
on: October 11, 2022In: Meeting News, WCLC News
Study Shows Shorter-Term Assessments Underestimate Pollution Exposure

During WCLC 22, Dr. Renelle Myers demonstrated the importance of considering long-term cumulative exposure to air pollutants when assessing individual lung cancer risk. Read more

POSEIDON Analysis Shows Sustained Benefit with Triplet Regimen Regardless of Mutational Status

Cody Holt
on: October 11, 2022In: Meeting News, WCLC News
POSEIDON Analysis Shows Sustained Benefit with Triplet Regimen Regardless of Mutational Status

Dr. Solange Peters showed 24-month overall survival rates were higher with tremelimumab, durvalumab, and chemotherapy versus chemotherapy alone across all subgroups, including those with KRAS, STK11, and KEAP1 mutations. Read more

IASLC CEO Reflects on WCLC 2022

Erin Jungmeyer
on: September 13, 2022In: Meeting News, WCLC News
IASLC CEO Reflects on WCLC 2022

In a Q&A with ILCN, Dr. Karen Kelly looks back at the moments that made lasting impressions and the presentations with the power to change the practice of thoracic oncology. Read more

Unclear Informed Consent Forms May Be a Barrier to Trial Participation

Cody Holt
on: September 13, 2022In: Meeting News, WCLC News
Unclear Informed Consent Forms May Be a Barrier to Trial Participation

Research presented during WCLC 2022 shows patient-centered summaries may help potential participants to better understand the benefits and risks of clinical trials. Read more

Get Up to Date on SCLC Brain Metastases, Neuroendocrine Tumors

Fred Gebhart
on: September 13, 2022In: Meeting News, WCLC News
Get Up to Date on SCLC Brain Metastases, Neuroendocrine Tumors

Experts evaluate available evidence comparing various strategies, including prophylactic cranial irradiation vs. surveillance, stereotactic radiosurgery vs. whole-brain radiotherapy, and more. Read more

Data Supports Smoking Cessation as Part Active Lung Cancer Treatment

Leah Lawrence
on: September 13, 2022In: Meeting News, WCLC News
Data Supports Smoking Cessation as Part Active Lung Cancer Treatment

Experts reviewed data that show smoking can reduce innate immunity and suppress the efficacy of anti-cancer agents, leading to poorer outcomes for patients who continue to smoke after their cancer diagnosis. Read more

Survey of Women with Lung Cancer Reveals High Levels of Sexual Dysfunction

Cody Holt
on: August 30, 2022In: Meeting News, WCLC News
Survey of Women with Lung Cancer Reveals High Levels of Sexual Dysfunction

The SHAWL study showed most women with lung cancer have little or no interest in sexual activity and experience increased pain and discomfort during sex following their diagnoses. Read more

Symposium Looks at Lung Cancer Technology Innovations

Fred Gebhart
on: August 30, 2022In: Meeting News, WCLC News
Symposium Looks at Lung Cancer Technology Innovations

Advances in radiotherapy, robotic surgery, and artificial intelligence promise to change the practice of thoracic oncology. Read more

Closing Plenary Addresses Access to Screening, Drugs

Fred Gebhart
on: August 30, 2022In: Meeting News, WCLC News
Closing Plenary Addresses Access to Screening, Drugs

Profession challenged to double survival rates within 5 years. Improving screening, reducing barriers to treatments will be key. Read more

1234567
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy